No. of cycles/all cycles (%)
|
706/744 (94.9)
|
38/744 (5.1)
|
–
|
Age, years
|
37 (23–46)a
|
39 (31–46)a
|
0.01
|
Gravida per patient, n
|
0 (0–7)a
|
0 (0–6)a
|
0.25
|
Parity per patient, n
|
0 (0–3)a
|
0 (0–4)a
|
0.02
|
BMI, kg/m2
|
21 (16–36)a
|
21 (18–31)a
|
0.42
|
Infertility period, years
|
6 (0–18)a
|
7 (0–16)a
|
0.09
|
Previous treatment cycles, n
|
2 (1–16)a
|
2 (1–14)a
|
0.87
|
No. of cycles with GnRH agonist long/no. of cycles (%)
|
190/706 (69.4)
|
19/38 (50.0)
|
0.02
|
No. of cycles with GnRH antagonist/no. of cycles/ (%)
|
216/706 (30.6)
|
19/38 (50.0)
|
0.02
|
Duration of hMG/rFSH, days
|
11 (7–21)a
|
12 (8–20)a
|
0.49
|
Dose of hMG/rFSH, IU
|
1425 (150–4800)a
|
1500 (900–4800)a
|
0.20
|
Hormone levelsb
| | | |
FSH, mIU/ml
|
13.4 (3.2–113.5)a
|
16.8 (7.5–43.5)a
|
<0.001
|
LH, mIU/ml
|
2.3 (0.1–26.8)a
|
3.8 (0.1–45.3)a
|
0.006
|
PRL, ng/ml
|
30.7 (0.6–314)a
|
21.3 (9.3–56.8)a
|
<0.001
|
Estradiol, pg/ml
|
1717 (88–15,768)a
|
633 (62–1970)a
|
<0.001
|
Progesterone, ng/ml
|
0.77 (0.05–10.9)a
|
0.51 (0.1–6.48)a
|
0.02
|
Endometrial thicknessb, mm
|
10.9 (4.6–21.2)a
|
10.3 (6.2–17.2)a
|
0.51
|
No. of follicles over 15.5 mmb, n
|
4 (1–16)a
|
2 (1–6)a
|
<0.001
|